AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $364,904 | +15.7% | 40,590 | 0.0% | 0.01% | 0.0% |
Q3 2023 | $315,384 | -19.7% | 40,590 | 0.0% | 0.01% | -25.0% |
Q2 2023 | $392,911 | -11.2% | 40,590 | +0.6% | 0.01% | -7.7% |
Q1 2023 | $442,400 | +254152.9% | 40,365 | 0.0% | 0.01% | +160.0% |
Q4 2022 | $174 | -99.9% | 40,365 | +32.9% | 0.01% | -37.5% |
Q3 2022 | $228,000 | -23.2% | 30,365 | +2.7% | 0.01% | -20.0% |
Q2 2022 | $297,000 | -16.8% | 29,565 | +2.5% | 0.01% | -9.1% |
Q1 2022 | $357,000 | +4.1% | 28,840 | +92.3% | 0.01% | +10.0% |
Q4 2021 | $343,000 | +19.1% | 15,000 | +15.4% | 0.01% | 0.0% |
Q3 2021 | $288,000 | +121.5% | 13,000 | +30.0% | 0.01% | +150.0% |
Q2 2021 | $130,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |